This site uses cookies to bring you the best experience. Find out more
Skip to main content


Find Out The Latest

You can keep in touch with exciting developments for The Oxford Science Park and its occupiers here.

Contact us on if you would like to know more about any of these stories.

You can also keep up to date by following us on Twitter or LinkedIn    

Scientists Professors Susan Iversen & Anthony Leggett honoured at The Oxford Science Park

  Scientists Professors Susan Iversen & Anthony Leggett honoured at The Oxford Science Park Names of two new buildings on Plot 16 announced as construction progresses Oxford, UK, September 16 2022 – Two leading scientists, experimental psychologist Professor Susan Iversen CBE FMedSci and Nobel Prize-winning theoretical physicist Professor Sir Anthony Leggett FRS HonFInstP are being honoured today at The Oxford Science Park (TOSP),... Read more

Evox Therapeutics expands its exosome manufacturing patent portfolio

EVOX THERAPEUTICS EXPANDS ITS EXOSOME MANUFACTURING PATENT PORTFOLIO Four newly issued patents cover key purification processes and methods of exogenous loading OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad range of exosome manufacturing methods and... Read more

Milestone reached in next phase of TOSP development following successful public consultation

Milestone reached in next phase of TOSP development  following successful public consultation Detailed new planning applications submitted for three new buildings  on Plots 23-26 Oxford, UK, September 6 2022 – Significant progress has been made in the expansion of The Oxford Science Park (TOSP), one of Europe's leading locations for science and technology companies, with the submission of detailed planning applications for three new... Read more

Gilead Sciences to Acquire MiroBio

Acquisition Provides Gilead with MiroBio’s Pipeline of Immune Checkpoint Agonists and Proprietary Discovery Platform MiroBio’s Scientific Approach to Restoring Immune Balance for the Treatment of Autoimmune Diseases Complements Gilead’s Inflammation Research and Development Strategy Foster City, Calif. and Oxford, U.K., August 4, 2022 – Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company... Read more

Digital Catapult unveils five firms to explore potential of Open RAN technology on SONIC Labs testbed

Digital Catapult, with support from its partner Ofcom, has onboarded five companies to its SONIC Labs programme to trial the integration of Open RAN (Radio Access Network) products into working end-to-end systems Participating organisations will work collaboratively with each other, Digital Catapult and Ofcom to integrate and test their products in lab and indoor mobile network settings, accelerating their route to... Read more